NEW YORK (GenomeWeb News) – Aviir today announced the completion of a $10 million tranche, completing a financing round started in December 2011 that raised a total of $30 million.

Proceeds will be used to build out the Irvine, Calif.-based firm's commercial infrastructure, speed up its nationwide commercial launch, and expand third-party reimbursement efforts, it said. It also plans to use proceeds to begin distribution of the company's cardiac risk test outside of the US, and to create additional laboratory testing services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.